Christopher Jewell

Plus aucun poste en cours

Fortune : 790 773 $ au 31/05/2026

45 ans

Consumer Services

Commercial Services

Profil

Christopher Jewell worked as a Professor at the University of Maryland from 2020 to 2024.
Dr. Jewell served as Chief Scientific Officer at Cartesian Therapeutics, Inc. (United States) in 2023 and continued in the same role at Cartesian Therapeutics, Inc. from 2023 to 2025.
Dr. Jewell earned a doctorate from the University of Wisconsin.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
0,36 %	14/04/2026	104 877 ( 0,36 % )	790 773 $	31/05/2026

Anciens postes connus de Christopher Jewell

Sociétés	Poste	Fin
University of Maryland University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	01/04/2024
Cartesian Therapeutics, Inc. Cartesian Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage company that develops mRNA cell therapies for autoimmune diseases	Directeur Technique/Scientifique/R&D	13/11/2023

Voir l'expérience en détail de Christopher Jewell

Formation de Christopher Jewell

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Christopher Jewell

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	3
University of Wisconsin University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Maryland University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Cartesian Therapeutics, Inc. Cartesian Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage company that develops mRNA cell therapies for autoimmune diseases	Commercial Services